Drug · DIN 02434695
SILDENAFIL
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since December 9, 2014.
- Drug Identification Number (DIN)
- 02434695
- Company (DIN owner)
- JAMP Pharma CorporationBoucherville, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Sildenafil G04BE03
- Class
- Human
- Record last updated
- June 23, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| SILDENAFIL (SILDENAFIL CITRATE) | 100.0 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- December 9, 2014: NOC 16421Abbreviated New Drug Submission (ANDS) · Licensing agreement between two companies
Other DINs named SILDENAFIL
- DIN 02317559 · Marketed
- DIN 02317575 · Marketed
- DIN 02317583 · Marketed
- DIN 02400693 · Marketed
- DIN 02400707 · Marketed
- DIN 02400715 · Marketed
- DIN 02406152 · Marketed
- DIN 02406160 · Marketed
- DIN 02424312 · Marketed
- DIN 02424320 · Marketed
- DIN 02537737 · Marketed
- DIN 02540770 · Marketed
- DIN 02424304 · Approved
- DIN 02433303 · Cancelled Pre Market
- DIN 02433311 · Cancelled Pre Market
- DIN 02433338 · Cancelled Pre Market
- DIN 02434679 · Approved
- DIN 02434687 · Approved
- DIN 02450925 · Approved
- DIN 02450933 · Approved